Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 8:00 PM
Fusion Pharmaceuticals Revenue
Fusion Pharmaceuticals reported an annual revenue of $2.07M, reflecting a 41.55% growth. For the quarter ending March 31, 2024, Fusion Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
$2.07M
Revenue Growth
41.55%
Price / Sales Ratio
304.9
Revenue / Employee
$20.48K
Employees
101
Market Cap
1.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|